US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Claritev Corporation

37.27

+3.199.36%

Post-market: 37.920.6500+1.74%19:30 EDT

Volume:199.24K

Turnover:7.24M

Market Cap:632.36M

PE:-2.19

High:37.34

Open:34.25

Low:34.25

Close:34.08

52wk High:74.07

52wk Low:11.50

Shares:16.97M

Float Shares:5.64M

Volume Ratio:1.61

T/O Rate:3.53%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-16.9879

EPS(LYR):-17.3000

ROE:-646.34%

ROA:1.19%

PB:-2.15

PE(LYR):-2.15

Loading ...

Overview Company News Filings

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

Claritev price target raised to $40 from $28 at Barclays

Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95

Claritev Shifts Payment Integrity Strategy Toward Pre-Pay Overpayment Prevention to Boost ROI

Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients

THOMSON REUTERS

Claritev Expands Marpai Partnership to Add Pre- and Post-Payment Claims Integrity Services

Multiplan Board Authorizes Management to Proceed with Annual Business Plan Implementation

Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44

Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

Claritev Analysts Raise Their Forecasts Following Q2 Earnings

Benzinga Earnings

Claritev Shifts Strategy to Earlier Cost Intelligence to Cut Avoidable Healthcare Spending

Claritev is Maintained at Buy by Canaccord Genuity

Guggenheim Sticks to Its Buy Rating for Claritev (CTEV)

Claritev price target raised to $45 from $40 at Citi

Analysts Offer Insights on Healthcare Companies: Claritev (CTEV) and Qiagen (QGEN)

Claritev Corp : Canaccord Genuity Raises Target Price to $43 from $37

THOMSON REUTERS

Claritev Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Calendar of U.S. Earnings Expected in the Week Ahead

Claritev Q2 EPS $(3.49) Beats $(4.21) Estimate, Sales $257.478M Beat $244.813M Estimate

Benzinga Earnings

Claritev Q2 2026 Net Loss Narrows to $59.2 Million; Revenue Rises 6.6% to $257.5 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/CTEV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CTEV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":37.27,"timestamp":1787342400000,"preClose":34.08,"halted":0,"volume":199239,"hourTrading":{"tag":"盘后","latestPrice":37.92,"preClose":37.27,"latestTime":"19:30 EDT","volume":4726,"amount":176209.5,"timestamp":1787355005859,"change":0.65,"changeRate":0.01744,"amplitude":0.01744},"delay":0,"changeRate":0.09360328638497667,"floatShares":5637600,"shares":16966900,"eps":-16.987898,"marketStatus":"Market Closed","change":3.19,"latestTime":"08-21 16:00:00 EDT","open":34.25,"high":37.34,"low":34.25,"amount":7244866.7898659995,"amplitude":0.090669,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-16.987898,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":34.08,"postHourTrading":{"tag":"盘后","latestPrice":37.92,"preClose":37.27,"latestTime":"19:30 EDT","volume":4726,"amount":176209.5,"timestamp":1787355005859,"change":0.65,"changeRate":0.01744,"amplitude":0.01744},"volumeRatio":1.6079435608764354,"impliedVol":1.0612,"impliedVolPercentile":0.4781},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTEV\",,,,,undefined,":{"symbol":"CTEV","floatShares":5637600,"roa":"1.19%","roe":"-646.34%","lyrEps":-17.3,"volumeRatio":1.6079435608764354,"shares":16966900,"dividePrice":0,"high":37.34,"amplitude":0.090669,"preClose":34.08,"low":34.25,"week52Low":11.5,"pbRate":"-2.15","psRate":"0.64","week52High":74.0699,"institutionHeld":0,"latestPrice":37.27,"eps":-16.987898,"divideRate":0,"volume":199239,"delay":0,"ttmEps":-16.987898,"open":34.25,"prevYearClose":42.75,"prevWeekClose":38.12,"prevMonthClose":22.71,"prevQuarterClose":34.11,"fiveDayClose":38.12,"twentyDayClose":21.61,"sixtyDayClose":23.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTEV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"CTEV","fiscalQuarterEnding":"2026/06","expectedEps":-4.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":-3.49},{"market":"US","date":"2026-05-07","symbol":"CTEV","fiscalQuarterEnding":"2026/03","expectedEps":-3.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-4.41},{"market":"US","date":"2026-02-23","symbol":"CTEV","fiscalQuarterEnding":"2025/12","expectedEps":-3.96,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"post","actualEps":-4.88},{"market":"US","date":"2025-11-07","symbol":"CTEV","fiscalQuarterEnding":"2025/09","expectedEps":-3.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":-4.07},{"market":"US","date":"2025-08-06","symbol":"CTEV","fiscalQuarterEnding":"2025/06","expectedEps":-2.69,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTEV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTEV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":6,"updateTime":1780113600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTEV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTEV","date":"2026-08-21","current":-2.193915,"percent":0.081301,"low":-3.349365,"twenty":-1.770169,"median":-1.307495,"eighty":-0.539856,"high":-0.170756,"avg":-1.204364,"sd":0.641749,"marketCap":577569539},"quantilePoints":[{"date":"2025-03-07","current":-0.191916,"twenty":-0.197447,"median":-0.191916,"eighty":-0.189456,"marketCap":315861468},{"date":"2025-03-14","current":-0.199101,"twenty":-0.197211,"median":-0.192162,"eighty":-0.187507,"marketCap":327686025},{"date":"2025-03-21","current":-0.195853,"twenty":-0.199101,"median":-0.195853,"eighty":-0.189456,"marketCap":322340677},{"date":"2025-03-28","current":-0.216127,"twenty":-0.207643,"median":-0.197969,"eighty":-0.191424,"marketCap":355708607},{"date":"2025-04-04","current":-0.196739,"twenty":-0.206718,"median":-0.199101,"eighty":-0.19231,"marketCap":323798499},{"date":"2025-04-11","current":-0.193589,"twenty":-0.205793,"median":-0.197132,"eighty":-0.19231,"marketCap":318615132},{"date":"2025-04-17","current":-0.199986,"twenty":-0.20599,"median":-0.198855,"eighty":-0.193117,"marketCap":329143847},{"date":"2025-04-25","current":-0.222131,"twenty":-0.206856,"median":-0.199101,"eighty":-0.193195,"marketCap":365589401},{"date":"2025-05-02","current":-0.218489,"twenty":-0.216127,"median":-0.199986,"eighty":-0.193707,"marketCap":359596132},{"date":"2025-05-09","current":-0.29687,"twenty":-0.216324,"median":-0.201167,"eighty":-0.194022,"marketCap":349553357},{"date":"2025-05-16","current":-0.381783,"twenty":-0.220201,"median":-0.203381,"eighty":-0.19477,"marketCap":449534692},{"date":"2025-05-23","current":-0.40691,"twenty":-0.226382,"median":-0.204415,"eighty":-0.195577,"marketCap":479120156},{"date":"2025-05-30","current":-0.501692,"twenty":-0.309019,"median":-0.20658,"eighty":-0.196207,"marketCap":590723101},{"date":"2025-06-06","current":-0.536032,"twenty":-0.373826,"median":-0.209041,"eighty":-0.196739,"marketCap":631156569},{"date":"2025-06-13","current":-0.526958,"twenty":-0.383151,"median":-0.211797,"eighty":-0.196817,"marketCap":620472929},{"date":"2025-06-20","current":-0.563252,"twenty":-0.405877,"median":-0.216127,"eighty":-0.197014,"marketCap":663207489},{"date":"2025-06-27","current":-0.596754,"twenty":-0.523385,"median":-0.218587,"eighty":-0.197388,"marketCap":702654774},{"date":"2025-07-03","current":-0.634165,"twenty":-0.535753,"median":-0.22026,"eighty":-0.197624,"marketCap":746704243},{"date":"2025-07-11","current":-0.664735,"twenty":-0.548455,"median":-0.222131,"eighty":-0.198609,"marketCap":782699891},{"date":"2025-07-18","current":-0.622299,"twenty":-0.561577,"median":-0.261715,"eighty":-0.199101,"marketCap":732733330},{"date":"2025-07-25","current":-0.582376,"twenty":-0.582376,"median":-0.309814,"eighty":-0.199101,"marketCap":685725314},{"date":"2025-08-01","current":-0.556552,"twenty":-0.579166,"median":-0.371453,"eighty":-0.199593,"marketCap":655318032},{"date":"2025-08-08","current":-1.363933,"twenty":-0.582376,"median":-0.381783,"eighty":-0.199986,"marketCap":904797938},{"date":"2025-08-15","current":-1.684055,"twenty":-0.596754,"median":-0.383039,"eighty":-0.199986,"marketCap":1117158561},{"date":"2025-08-22","current":-1.705165,"twenty":-0.609038,"median":-0.401745,"eighty":-0.201167,"marketCap":1131162171},{"date":"2025-08-29","current":-1.770481,"twenty":-0.629977,"median":-0.507694,"eighty":-0.20166,"marketCap":1174490987},{"date":"2025-09-05","current":-1.68033,"twenty":-0.646839,"median":-0.521375,"eighty":-0.202762,"marketCap":1114687336},{"date":"2025-09-12","current":-1.530824,"twenty":-0.692989,"median":-0.533938,"eighty":-0.203588,"marketCap":1015508829},{"date":"2025-09-19","current":-1.375606,"twenty":-1.377791,"median":-0.536381,"eighty":-0.203963,"marketCap":912541110},{"date":"2025-09-26","current":-1.23802,"twenty":-1.366268,"median":-0.537986,"eighty":-0.204336,"marketCap":821270524},{"date":"2025-10-03","current":-1.152588,"twenty":-1.327376,"median":-0.544198,"eighty":-0.20536,"marketCap":764597092},{"date":"2025-10-10","current":-1.44862,"twenty":-1.376798,"median":-0.552224,"eighty":-0.206383,"marketCap":960977125},{"date":"2025-10-17","current":-1.403918,"twenty":-1.382559,"median":-0.554947,"eighty":-0.207131,"marketCap":931322422},{"date":"2025-10-24","current":-1.649535,"twenty":-1.412162,"median":-0.558366,"eighty":-0.208608,"marketCap":1094258540},{"date":"2025-10-31","current":-1.640594,"twenty":-1.453339,"median":-0.563531,"eighty":-0.2091,"marketCap":1088327600},{"date":"2025-11-07","current":-1.538771,"twenty":-1.530228,"median":-0.579166,"eighty":-0.210084,"marketCap":1020780776},{"date":"2025-11-14","current":-2.137789,"twenty":-1.578507,"median":-0.589565,"eighty":-0.211502,"marketCap":730433464},{"date":"2025-11-21","current":-2.187607,"twenty":-1.633144,"median":-0.596754,"eighty":-0.215261,"marketCap":747454878},{"date":"2025-11-28","current":-2.615165,"twenty":-1.640942,"median":-0.60834,"eighty":-0.216127,"marketCap":893541571},{"date":"2025-12-05","current":-1.787134,"twenty":-1.682416,"median":-0.609806,"eighty":-0.216422,"marketCap":610622545},{"date":"2025-12-12","current":-1.88435,"twenty":-1.687561,"median":-0.622299,"eighty":-0.217741,"marketCap":643839090},{"date":"2025-12-19","current":-1.988338,"twenty":-1.707649,"median":-0.634165,"eighty":-0.218607,"marketCap":679369224},{"date":"2025-12-26","current":-2.064756,"twenty":-1.732682,"median":-0.647217,"eighty":-0.219198,"marketCap":705479742},{"date":"2026-01-02","current":-2.067658,"twenty":-1.769935,"median":-0.66969,"eighty":-0.220083,"marketCap":706471281},{"date":"2026-01-09","current":-1.509511,"twenty":-1.763775,"median":-0.697121,"eighty":-0.220595,"marketCap":515765349},{"date":"2026-01-16","current":-1.45389,"twenty":-1.7451,"median":-1.219145,"eighty":-0.221029,"marketCap":496760858},{"date":"2026-01-23","current":-1.453407,"twenty":-1.733974,"median":-1.267698,"eighty":-0.222131,"marketCap":496595602},{"date":"2026-01-30","current":-1.302504,"twenty":-1.730745,"median":-1.277756,"eighty":-0.226264,"marketCap":445035592},{"date":"2026-02-06","current":-1.243013,"twenty":-1.721556,"median":-1.273802,"eighty":-0.226559,"marketCap":424709050},{"date":"2026-02-13","current":-0.966358,"twenty":-1.711374,"median":-1.266581,"eighty":-0.29687,"marketCap":330182367},{"date":"2026-02-20","current":-1.127418,"twenty":-1.706407,"median":-1.25317,"eighty":-0.305635,"marketCap":385212761},{"date":"2026-02-27","current":-0.825068,"twenty":-1.703973,"median":-1.240517,"eighty":-0.309416,"marketCap":234552084},{"date":"2026-03-06","current":-1.03119,"twenty":-1.699304,"median":-1.200271,"eighty":-0.346407,"marketCap":293148724},{"date":"2026-03-13","current":-0.932787,"twenty":-1.693898,"median":-1.145072,"eighty":-0.367715,"marketCap":265174622},{"date":"2026-03-20","current":-0.893193,"twenty":-1.685808,"median":-1.125483,"eighty":-0.371872,"marketCap":253918770},{"date":"2026-03-27","current":-0.928129,"twenty":-1.68187,"median":-1.089934,"eighty":-0.374385,"marketCap":263850404},{"date":"2026-04-02","current":-0.979951,"twenty":-1.680728,"median":-1.034393,"eighty":-0.379047,"marketCap":278582328},{"date":"2026-04-10","current":-1.041088,"twenty":-1.661853,"median":-1.024785,"eighty":-0.382034,"marketCap":295962687},{"date":"2026-04-17","current":-1.144149,"twenty":-1.646486,"median":-1.027988,"eighty":-0.382369,"marketCap":325261006},{"date":"2026-04-24","current":-1.181996,"twenty":-1.643002,"median":-1.041088,"eighty":-0.383151,"marketCap":336020276},{"date":"2026-05-01","current":-1.416649,"twenty":-1.641469,"median":-1.087406,"eighty":-0.393983,"marketCap":402727750},{"date":"2026-05-08","current":-1.436454,"twenty":-1.640942,"median":-1.117261,"eighty":-0.40141,"marketCap":411577020},{"date":"2026-05-15","current":-1.396438,"twenty":-1.641469,"median":-1.133463,"eighty":-0.404844,"marketCap":400111607},{"date":"2026-05-22","current":-1.401198,"twenty":-1.641023,"median":-1.127418,"eighty":-0.463779,"marketCap":401475430},{"date":"2026-05-29","current":-1.461292,"twenty":-1.640924,"median":-1.144149,"eighty":-0.506494,"marketCap":418693697},{"date":"2026-06-05","current":-1.640383,"twenty":-1.640924,"median":-1.167292,"eighty":-0.515428,"marketCap":470007542},{"date":"2026-06-12","current":-1.905748,"twenty":-1.641657,"median":-1.200271,"eighty":-0.520705,"marketCap":546040681},{"date":"2026-06-18","current":-1.770091,"twenty":-1.674171,"median":-1.236729,"eighty":-0.525172,"marketCap":507171722},{"date":"2026-06-26","current":-2.0658,"twenty":-1.686673,"median":-1.248091,"eighty":-0.528354,"marketCap":591899234},{"date":"2026-07-02","current":-1.927763,"twenty":-1.697502,"median":-1.259914,"eighty":-0.533938,"marketCap":552348363},{"date":"2026-07-10","current":-1.957512,"twenty":-1.711374,"median":-1.268816,"eighty":-0.535753,"marketCap":560872258},{"date":"2026-07-17","current":-1.830185,"twenty":-1.733974,"median":-1.276749,"eighty":-0.536032,"marketCap":524389989},{"date":"2026-07-24","current":-1.384538,"twenty":-1.747881,"median":-1.279495,"eighty":-0.53673,"marketCap":396702050},{"date":"2026-07-31","current":-1.402983,"twenty":-1.736755,"median":-1.28934,"eighty":-0.537065,"marketCap":401986864},{"date":"2026-08-07","current":-1.596949,"twenty":-1.731391,"median":-1.299807,"eighty":-0.537819,"marketCap":457562656},{"date":"2026-08-14","current":-2.527372,"twenty":-1.754145,"median":-1.304922,"eighty":-0.539215,"marketCap":715521887},{"date":"2026-08-21","current":-2.040096,"twenty":-1.770169,"median":-1.307495,"eighty":-0.539856,"marketCap":577569539}],"updateTime":1787467711776},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTEV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661250734","title":"U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250734?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:26","pubTimestamp":1787297213,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC SolutionsAug 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, incl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADI","IXN","FIX","MATW","CHAT","BCAL","MBX","AMP","EGGY","MTSI","GTLB","DOCS","COTY","P","ADSK","ACEL","DV","HRZN","MRVL","LEGR","BAI","EBS","HCAT","MCHP","FTAI","PI","LYTS","DISK","FERG","IMA","AMD","QBTS","AMYY","LMB","HL","FTH","BWMN","DE","SMHX","VEGI","CTEV","APP","ABT","MU","TRFK","ECG","AVGU","AAP","AVGO","INNV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661902236","title":"Claritev price target raised to $40 from $28 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2661902236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661902236?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243412,"startTime":"0","endTime":"0","summary":"Barclays analyst Glen Santangelo raised the firm’s price target on Claritev (CTEV) to $40 from $28 and keeps an Overweight rating on the shares. Pu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-40-from-28-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-40-from-28-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660978054","title":"Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2660978054","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660978054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:08","pubTimestamp":1787087285,"startTime":"0","endTime":"0","summary":"Claritev Chief Growth Officer Tiffani Misencik sells 8,850 shares worth $354,592.95Tiffani Misencik, SVP and Chief Growth Officer, sold 8,850 shares of Class A common stock on Aug. 14, 2026.Sale price","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL6k9k4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660462560","title":"Claritev Shifts Payment Integrity Strategy Toward Pre-Pay Overpayment Prevention to Boost ROI","url":"https://stock-news.laohu8.com/highlight/detail?id=2660462560","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660462560?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:06","pubTimestamp":1787054801,"startTime":"0","endTime":"0","summary":"Claritev shifts payment integrity strategy toward pre-pay overpayment prevention to boost ROIClaritev outlined a shift in payment integrity toward pre-payment prevention, aiming to reduce improper pay","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8TbdhV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480741","title":"Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480741?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:02","pubTimestamp":1786971759,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0VD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRAI","CTEV","BK4173","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480718","title":"Claritev Expands Marpai Partnership to Add Pre- and Post-Payment Claims Integrity Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480718","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480718?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:01","pubTimestamp":1786971667,"startTime":"0","endTime":"0","summary":"Claritev expands Marpai partnership to add pre- and post-payment claims integrity servicesClaritev expanded its relationship with Marpai to provide pre- and post-payment integrity services across clai","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL69NhTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","CTEV","MRAI","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121490","title":"Multiplan Board Authorizes Management to Proceed with Annual Business Plan Implementation","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121490","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121490?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:01","pubTimestamp":1786741316,"startTime":"0","endTime":"0","summary":"Multiplan board authorizes management to proceed with annual business plan implementationMultiplan’s board met Aug. 6, 2026 to review business performance, project execution, strategic priorities.Dire","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1TKwVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900686","title":"Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900686","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900686?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:14","pubTimestamp":1786565673,"startTime":"0","endTime":"0","summary":"Claritev SVP, Chief Strategy Officer William B. Mintz sells 8,431 common shares for $288,277.44Claritev SVP, Chief Strategy Officer William B. Mintz sold 8,431 Class A common shares on Aug. 10, 2026.S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL6PZKmT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658044979","title":"Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658044979","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658044979?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532400,"startTime":"0","endTime":"0","summary":"-- Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","LABU","CTEV","MAA","SPRE","BK4022","IND","R","HUMA","BK4585","BK4167","BK4588","BK4139","BK4563","BK4215","AV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658932071","title":"Claritev Analysts Raise Their Forecasts Following Q2 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2658932071","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658932071?lang=en_us&edition=fundamental","pubTime":"2026-08-10 22:45","pubTimestamp":1786373120,"startTime":"0","endTime":"0","summary":"CTEV reported better-than-expected Q2 results and raised FY26 sales guidance. Analysts maintain Buy ratings with increased price targets.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/08/61078315/claritev-analysts-raise-their-forecasts-following-q2-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931597","title":"Claritev Shifts Strategy to Earlier Cost Intelligence to Cut Avoidable Healthcare Spending","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931597?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:10","pubTimestamp":1786367409,"startTime":"0","endTime":"0","summary":"Claritev shifts strategy to earlier cost intelligence to cut avoidable healthcare spendingClaritev outlined a shift to act on healthcare cost drivers earlier in the care cycle, aiming to reduce avoida","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL7Xrsjk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936458","title":"Claritev is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936458","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936458?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:21","pubTimestamp":1786364460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893374","title":"Guggenheim Sticks to Its Buy Rating for Claritev (CTEV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893374?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:37","pubTimestamp":1786361821,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Jason Cassorla reiterated a Buy rating on Claritev on August 7 and set a price target of $44.00. The company’s shares closed las...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-buy-rating-for-claritev-ctev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-its-buy-rating-for-claritev-ctev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980569","title":"Claritev price target raised to $45 from $40 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980569","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980569?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:40","pubTimestamp":1786358435,"startTime":"0","endTime":"0","summary":"Citi analyst Daniel Grosslight raised the firm’s price target on Claritev (CTEV) to $45 from $40 and keeps a Buy rating on the shares. Published fi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-45-from-40-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-raised-to-45-from-40-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893749","title":"Analysts Offer Insights on Healthcare Companies: Claritev (CTEV) and Qiagen (QGEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893749?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:10","pubTimestamp":1786349406,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Claritev (CTEV) and Qiagen (QGEN) with bullish senti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-claritev-ctev-and-qiagen-qgen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-claritev-ctev-and-qiagen-qgen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2125909247.SGD","BK4137","LU0128526141.USD","QGEN","LU2433249047.HKD","BK4167","CTEV","LU0029874061.USD","BK4588","LABU","BK4121","LU1923622614.USD","LU2125909593.SGD","HCSG","BK4581","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658768607","title":"Claritev Corp : Canaccord Genuity Raises Target Price to $43 from $37","url":"https://stock-news.laohu8.com/highlight/detail?id=2658768607","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658768607?lang=en_us&edition=fundamental","pubTime":"2026-08-10 13:53","pubTimestamp":1786341192,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN44708E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657459649","title":"Claritev Corp Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657459649","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657459649?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:31","pubTimestamp":1786109510,"startTime":"0","endTime":"0","summary":"Claritev Corp reports results for the quarter ended June 30 - Earnings SummaryClaritev CorpCTEV.Nreported a quarterly adjusted loss of $3.49 per share for the quarter ended June 30, higher than the sa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614462","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657614462?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:00","pubTimestamp":1786096800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ACM Research Inc. Class A                       2Q       .42       BMO. Algonquin Power & Utilities Corp.                2Q       .03   6:30 AM. Alpha Metallurgical Resources Inc.               2Q      (.43)  7:30 AM. Construction Partners Inc. Class A              3Q      1.01       BMO. Kimbell Royalty Partners LP                      2Q       .23   7:00 AM. Park Hotels & Resorts Inc.                        2Q       .25       AMC. Plains All American Pipeline L.P.                2Q       .38   7:30 AM. Plains GP Hldgs LP Class A                      2Q       .46   7:30 AM. Rapid Micro BioSyss Inc. Class A                2Q      (.24)      BMO. Spectrum Brands Hldgs Inc.                       3Q      1.46   6:30 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODI","CRC","AMTM","CNDT","CNTY","ACVA","AQN","BBIO","DCH","CLMT","CEVA","ASTS","DMAC","BCSF","CTEV","ELTX","ARQ","ANAB","EMBC","ACHR","BWMN","ALC","BODI","AIOT","AAON","DH","AXSM","BTDR","BKD","CCAP","CIB","CAMT","ACMR","CBLL","AMR","ACH","BZH","APEI","ELVA","DCBO","ANIP","DCGO","EMA","UA","CGC","ATMU","B","ALMR","CECO","ACM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657619214","title":"Claritev Q2 EPS $(3.49) Beats $(4.21) Estimate, Sales $257.478M Beat $244.813M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657619214","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657619214?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:23","pubTimestamp":1786094607,"startTime":"0","endTime":"0","summary":"Claritev (NYSE:CTEV) reported quarterly losses of $(3.49) per share which beat the analyst consensus estimate of $(4.21) by 17.1 percent. This is a 8.4 percent increase over losses of $(3.81) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61030820/claritev-q2-eps-3-49-beats-4-21-estimate-sales-257-478m-beat-244-813m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616098","title":"Claritev Q2 2026 Net Loss Narrows to $59.2 Million; Revenue Rises 6.6% to $257.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616098","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657616098?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:01","pubTimestamp":1786093290,"startTime":"0","endTime":"0","summary":"Claritev Q2 2026 net loss narrows to $59.2 million; revenue rises 6.6% to $257.5 millionClaritev posted Q2 2026 revenue of USD 257.5 million, up 6.6% from a year earlier.Net loss narrowed to USD 59.2 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDLbdFvrm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":112,"code":"91000000","status":"200"}]}}